Association of lincRNA-p21 Haplotype with Coronary Artery Disease in a Chinese Han Population

Disease Markers

Volumn 2016, Issue , 2016, Pages

  Tang, Sai Sai ^a   Cheng, Jie ^a   Cai, Meng Yun ^a   Yang, Xi Li ^b   Liu, Xin Guang ^a   Zheng, Bi Ying ^a   Xiong, Xing Dong ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LONG UNTRANSLATED RNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN P21; TRIACYLGLYCEROL; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; CANCER STAGING; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; FOLLOW UP; GENETICS; METABOLISM; MIDDLE AGED; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

BIOMARKERS; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING;

EID: 84975290464     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2016/9109743     Document Type: Article

References (32)

1. J. Hata and Y. Kiyohara, "Epidemiology of stroke and coronary artery disease in Asia," Circulation Journal, vol. 77, no. 8, pp. 1923-1932, 2013.
2. P. Greenland, J. S. Alpert, G. A. Beller et al., "2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines," Journal of the American College of Cardiology, vol. 56, no. 25, pp. e50-e103, 2010.
3. H. Won, P. Natarajan, A. Dobbyn et al., "Disproportionate contributions of select genomic compartments and cell types to genetic risk for coronary artery disease," PLoS Genetics, vol. 11, no. 10, Article ID e1005622, 2015.
4. X.-D. Xiong, M. Cho, X.-P. Cai et al., "A common variant in premiR-146 is associated with coronary artery disease risk and its mature miRNA expression," Mutation Research, vol. 761, pp. 15-20, 2014.
5. J. L. Rinn and H. Y. Chang, "Genome regulation by long noncoding RNAs," Annual Review of Biochemistry, vol. 81, pp. 145-166, 2012.
6. V. A. Moran, R. J. Perera, and A. M. Khalil, "Emerging functional and mechanistic paradigms of mammalian long noncoding RNAs," Nucleic Acids Research, vol. 40, no. 14, pp. 6391-6400, 2012.
7. J. C. Scheuermann and L. A. Boyer, "Getting to the heart of thematter: Long non-coding RNAs in cardiac development and disease," The EMBO Journal, vol. 32, no. 13, pp. 1805-1816, 2013.
8. M. Vausort, D. R. Wagner, and Y. Devaux, "Long noncoding RNAs in patients with acute myocardial infarction," Circulation Research, vol. 115, no. 7, pp. 668-677, 2014.
9. Y. Liu, H. K. Sanoff, H. Choet al., "INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis," PLoS ONE, vol. 4, no. 4, Article IDe5027, 2009.
10. J. Shanker, P. Arvind, S. Jambunathan, J. Nair, and V. V. Kakkar, "Genetic analysis of the 9p21.3CADrisk locus in Asian Indians," Thrombosis and Haemostasis, vol. 111, no. 5, pp. 960-969, 2014.
11. W. Gao, M. Zhu, H. Wang et al., "Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population," Mutation Research, vol. 772, pp. 15-22, 2015.
12. N. Ishii, K. Ozaki, H. Sato et al., "Identification of a novel noncoding RNA, MIAT, that confers risk of myocardial infarction," Journal of Human Genetics, vol. 51, no. 12, pp. 1087-1099, 2006.
13. W. Ahmed, I. S. Ali, M. Riaz et al., "Association of ANRIL polymorphism (rs1333049:C>G) with myocardial infarction and its pharmacogenomic role in hypercholesterolemia," Gene, vol. 515, no. 2, pp. 416-420, 2013.
14. J.-H. Yoon, S. Srikantan, and M. Gorospe, "MS2-TRAP (MS2-tagged RNA affinity purification): tagging RNA to identify associated miRNAs," Methods, vol. 58, no. 2, pp. 81-87, 2012.
15. C. J. Wilusz and J. Wilusz, "HuR and translation-the missing linc(RNA)," Molecular Cell, vol. 47, no. 4, pp. 495-496, 2012.
16. M. Huarte, M. Guttman, D. Feldser et al., "A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response," Cell, vol. 142, no. 3, pp. 409-419, 2010.
17. M. Işin, E. Uysaler, E. Özgür et al., "Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease," Frontiers in Genetics, vol. 6, article 168, 2015.
18. Y. J. Jiang and D. D. Bikle, "LncRNA profiling reveals new mechanism for VDR protection against skin cancer formation," Journal of Steroid Biochemistry and Molecular Biology, vol. 144, partA, pp. 87-90, 2014.
19. J. R. Hall, Z. J. Messenger, H. W. Tam, S. L. Phillips, L. Recio, and R. C. Smart, "Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes," Cell Death and Disease, vol. 6, no. 3, Article ID e1700, 2015.
20. H. Zhai, A. Fesler, K. Schee, Ø. Fodstad, K. Flatmark, and J. Ju, "Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer," Clinical Colorectal Cancer, vol. 12, no. 4, pp. 261-266, 2013.
21. G. Wang, Z. Li, Q. Zhao et al., "LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway," Oncology Reports, vol. 31, no. 4, pp. 1839-1845, 2014.
22. M. Isin, E. Ozgur, G. Cetin et al., "Investigation of circulating lncRNAs in B-cell neoplasms," Clinica Chimica Acta, vol. 431, pp. 255-259, 2014.
23. C. F. Spurlock III, J. T. Tossberg, B. K. Matlock, N. J. Olsen, and T. M. Aune, "Methotrexate inhibits NF-κB activity via long intergenic (noncoding) RNA-p21 induction," Arthritis and Rheumatology, vol. 66, no. 11, pp. 2947-2957, 2014.
24. Y. Ning, F. Yong, Z. Haibin, S. Hui, Z. Nan, and Y. Guangshun, "LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma," Oncotarget, vol. 6, no. 29, pp. 28151-28163, 2015.
25. G. Wu, J. Cai, Y. Han et al., "LincRNA-p21 regulates neointima formation, vascular smoothmuscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity," Circulation, vol. 130, no. 17, pp. 1452-1465, 2014.
26. J. Cheng, M. Cho, J.-M. Cen et al., "A TagSNP in SIRT1 gene confers susceptibility tomyocardial infarction in a Chinese Han population," PLoS ONE, vol. 10, no. 2, Article ID e0115339, 2015.
27. T. J. Wang, B. H. Nam, R. B. D'Agostino et al., "Carotid intimamedia thickness is associated with premature parental coronary heart disease: the Framingham Heart Study," Circulation, vol. 108, no. 5, pp. 572-576, 2003.
28. S. R. Thompson, P. A. McCaskie, J. P. Beilby et al., "IL18 haplotypes are associated with serum IL-18 concentrations in a population-based study and a cohort of individuals with premature coronary heart disease," Clinical Chemistry, vol. 53, no. 12, pp. 2078-2085, 2007.
29. A.V. Chobanian, G. L. Bakris, H. R. Black et al., "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure," Hypertension, vol. 42, no. 6, pp. 1206-1252, 2003.
30. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, "Haploview: analysis and visualization of LDand haplotypemaps," Bioinformatics, vol. 21, no. 2, pp. 263-265, 2005.
31. P. I. W. de Bakker, N. P. Burtt, R. R. Graham et al., "Transferability of tag SNPs in genetic association studies in multiple populations," Nature Genetics, vol. 38, no. 11, pp. 1298-1303, 2006.
32. Y. Y. Shi and L. He, "SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci," Cell Research, vol. 15, no. 2, pp. 97-98, 2005.